Arsenal Capital Partners

Arsenal Capital Partners is a private equity firm based in New York, established in 2000. The firm specializes in providing investment services to lower middle-market companies within the healthcare and industrial sectors. By focusing on these specific areas, Arsenal Capital Partners aims to drive growth and create value through strategic investments.

George A. Abd

Operating Partner

Ryan Berman

Principal

Darius C. Brooks

VP

Robbie Cahill

Vice President

Robert Cahill

Principal

Ian Chan

Senior Associate

Tony Clewlow

Senior Associate

Richard Colonel

Operating Partner, Sales and Marketing

Donald Deieso

Operating Partner

Jessica Delfino

Principal

John DiGiovanni

Investment Partner

Robert Farmer

Associate

Matt Fernandes

Associate

Sal Gagliardo

Operating Partner

Devon Gobbo

Associate

Jeremy Goldberg

Operating Partner, Sourcing and Business Development

Gene Gorbach

Investment Partner

Eugene Gorbach

Investment Partner

Patricia Grad

Senior MD, Head of Investor Relations

Ayushi Gupta

Associate

Henrik Hartmann

Senior Associate

Thomsen Hearne

Associate

Taylor Holland

Vice President

Peter B. Hurley

Associate

David Kim

Associate

Jeffrey Kovach

Managing Partner

Jonathan Laifer

Vice President

Rick Li

Senior Associate

Paul Lipari

Associate

Alex Mansfield

Principal

Joelle Marquis

Senior Partner

Jon Mattern

VP

Jonathan Mattern

Associate

Steve Mclean

Senior Partner

Madison Meyer

Investor Relations Analyst

Terrence Mullen

Managing Partner

Terry Mullen

Managing Partner

Blake Niehaus

Senior Associate

Michael J. O'Connor

Operating Partner

Brian Orkin

Investment Partner

Mark Pfister

Associate

Barry Graham Porter

Industry and Operations Partner

BG Porter

Operating Partner

Joseph Rooney

Investment Partner

Tristan Saeed

Associate

Joseph Salley

Operating Partner

Frank Scrudato

CFO, CCO

Roy Seroussi

Investment Partner

Jacqueline Simek

Vice President of Finance

Robert Sorrel

Principal

David Spaight

Operating Partner

Dave Spaight

Operating Partner

Harish Sriram

Associate

John Televantos

Senior Partner

Matthew Teller

Vice President

Alexandra Wang

Associate

Robert Weiner

Associate

Jacob Weiss

Associate

Yoonmo Yang

Vice President

Tim Zappala

Senior Partner

Elisabetta Zhang

Vice President of Finance

Jennifer Zhou

Vice President

Past deals in New Jersey

WCG

Private Equity Round in 2019
WCG is a prominent provider of regulatory and ethical review services for human research, focusing on enhancing the quality and efficiency of clinical studies. The company reviews new research protocols and offers a range of services including clinical and human gene therapy research, laboratory biosafety consulting, and solutions for human research protections. WCG also provides online learning resources, an electronic informed consent solution to streamline clinical processes, oncology review services, and a cloud-based platform for managing research activities. Serving a diverse clientele that includes large pharmaceutical companies, biotechnology firms, and contract research organizations, WCG is committed to accelerating the delivery of new treatments while upholding high standards of human subject protection. Founded in 2012 and headquartered in Princeton, New Jersey, WCG operates multiple locations across the United States and in Tokyo, Japan, and has established a strategic partnership with InformedDNA.

Breen Color Concentrates

Acquisition in 2017
Breen Color has been providing custom color and additive concentrates to the plastics industry for over 30 years. Since its inception in 1976, Breen has grown in size and capability and has established itself as one of the leading suppliers of plastic colorants to the blow molding, wire and cable, extrusion/injection molding, compounding and roto-molding markets. Breen’s personal commitment to meeting the needs of the plastics industry is supported by a staff comprised of long term Breen employees and new additions of experienced professional managers in General Management, Sales and Marketing, Manufacturing, Technical and Finance. Breen’s formulation experience in a wide range of polymers has created a diverse portfolio of standard and custom color concentrates with which they can meet many of your immediate needs. Their extensive knowledge and database of pigment, resin and additive properties can also be utilized to rapidly develop custom color concentrates to meet any special requirement. Breen Color’s compounding equipment has been customized to provide rapid order turnaround while maintaining the exacting quality requirements of an ISO-9001 registered facility. Their pelletizing equipment is state-of-the-art and is capable of producing multiple pellet geometries. This ensures product consistency regardless of order size and provides the option of choosing the pellet form (diced, underwater cut or minibead) that works best in your application.